2026-525748-14-00CompletedPhase 1
A clinical trial of MK-1824 in healthy participants (MK-1824-001)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 12 May 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 8 Apr 2026
- Start date
- 26 May 2026
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2026-525748-14-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 16
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Leuven | Leuven | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.